Skip to content

Impact of neoadjuvant chemotherapy on postoperative complications after endoscopic mastectomy and immediate breast reconstruction with implant for breast cancer

Impact of neoadjuvant chemotherapy on postoperative complications after endoscopic mastectomy and immediate breast reconstruction with implant for breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-14004744
Enrollment
Unknown
Registered
2014-06-02
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Group with neoadjuvant chemotherapy :Neoadjuvant chemotherapy and surgery

Sponsors

Southwest Hospital of Third Military University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Femaleage from 18 years old to 60 years, preoperative biopsy confirmed the diagnosis as invasive breast cancer; 2) Tumor size less than 3cmand there is no ulceration on the surface of the skin, and not invaded to the skin or muscle; 3) Clinical node-negative; 4) Patients without funtionnal failure of heart,lung,liver,kidney etc; 5) Patients without a history of radiotherapy to the breast and chest wall; 6) Signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Any part of the breast skin develop orange-peel sign; 2) Crater nipple or deflected nipple; 3) Breast cancer during pregnancy and lactation; 4) Distant metastasis; 5) Unwilling to undergo the surgery; 6) Researchers find that who"s not suitable for this research.

Design outcomes

Primary

MeasureTime frame
Circulating Tumor Cells;Operation situation;Infection;Nipple areola necrosis;Edema of the upper extremity;Capsular contracture;

Secondary

MeasureTime frame
Capsular contracture;Distant metastasis;

Countries

China

Contacts

Public ContactFan Linjun

Southwest Hospital of Third Military University

flj212@medmail.com.cn+86 13389668035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026